Amgen Inc. News Headlines

Get AMGN Alerts
*Delayed - data as of Nov. 26, 2014  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By
AstraZeneca/Amgen's Brodalumab Excels in Psoriasis Study - Analyst Blog
11/26/2014 5:30:00 PM -

Alexion's (ALXN) Soliris Gets Orphan Drug Status in Japan - Analyst Blog
11/26/2014 5:10:00 PM -

Dividend Aristocrats In Focus Part 45: AbbVie
11/26/2014 12:57:00 PM - Seeking Alpha

Why A Merck Clinical Trial May Help Amgen And Regeneron Shares To Set Higher Highs
11/26/2014 11:09:00 AM - Seeking Alpha

My Strategy For Objective, Emotionless Dividend Growth Investing
11/26/2014 10:10:00 AM - Seeking Alpha

Should Gilead Sciences, Inc. Pay a Dividend?
11/26/2014 9:15:03 AM - Motley Fool

Health Care Sector Update for 11/26/2014: ARWR, AMGN, AZN
11/26/2014 8:43:52 AM - MT Newswires

Psoriasis Drug Trial Meets Goals, Reimbursement Rate For Cologuard Finalized
11/26/2014 3:50:00 AM - RTT News

Amgen,AstraZeneca Report Positive Results From Phase 3 Study Of Brodalumab
11/25/2014 10:06:00 PM - RTT News

Last Phase 3 brodalumab psoriasis trial successful
11/25/2014 4:47:00 PM - Seeking Alpha

Amgen Ends Gastric Cancer Drug Studies on Safety Review - Analyst Blog
11/25/2014 1:20:00 PM -

I'm Letting Amgen Cool Down Before Buying Any More Shares Right Now
11/25/2014 11:17:00 AM - Seeking Alpha

Today's Market: Record Highs Continue, Stocks In The News
11/25/2014 10:25:00 AM - Seeking Alpha

Drug makers face pushback on pricey meds
11/25/2014 8:18:00 AM - Seeking Alpha

Novartis' Psoriasis Drug Cosentyx Backed for EU Approval - Analyst Blog
11/24/2014 6:40:00 PM -

Holiday Fever Takes Hold Of Stock Investors, But A Pullback Is Needed
11/24/2014 4:14:00 PM - Seeking Alpha

JANA Partners opens a stake in Amgen
11/24/2014 12:00:00 PM - Market Realist

Amgen Terminates Clinical Studies Of Rilotumumab In Advanced Gastric Cancer
11/24/2014 9:25:00 AM - RTT News

JANA Partners adds a large stake in Dollar General
11/24/2014 8:00:00 AM - Market Realist

Gilead Sciences Inc. Just Paid $125 Million for Something It Can't Use for a Year
11/24/2014 7:53:03 AM - Motley Fool

Week In Review: Cross-Border Deals Dominate The Week's News
11/24/2014 3:46:00 AM - Seeking Alpha

Tracking Dan Loeb's Third Point Portfolio - Q3 2014 Update
11/24/2014 2:26:00 AM - Seeking Alpha

DealBook: When activist investors aim at strong companies, America loses
11/22/2014 8:25:00 AM - Seeking Alpha

Highlights of activist fund JANA Partners’ 3Q 13F
11/21/2014 8:30:00 PM - Market Realist

Amgen and AbbVie Strengthen Manufacturing Facilities in Asia - Analyst Blog
11/21/2014 5:00:00 PM -